{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:49:45Z","timestamp":1787500185256,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>For the detection of malignant mesothelioma additional markers are needed besides the established panel consisting of calretinin and mesothelin. The aim of this study was the identification and verification of long non-coding RNAs (lncRNAs) as complementing circulating markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Candidate lncRNAs were identified in silico using previously published RNA expression profiles and verified using quantitative PCR (qPCR) in mesothelioma cell lines as well as human plasma samples from mesothelioma patients and asbestos-exposed controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>GAS5<\/jats:italic>\n                      (growth arrest-specific transcript\u00a05) as a single marker is marked by a low sensitivity of 14%, but the combination of\n                      <jats:italic>GAS5<\/jats:italic>\n                      with calretinin and mesothelin increased the panel\u2019s sensitivity from 64 to 73% at a predefined specificity of 97%. Circulating\n                      <jats:italic>GAS5<\/jats:italic>\n                      is not affected by pleurectomy before blood collection, age, or smoking status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>GAS5<\/jats:italic>\n                      is verified as an appropriate circulating marker for the supplement of calretinin and mesothelin to detect malignant mesothelioma. Although the sensitivity of\n                      <jats:italic>GAS5<\/jats:italic>\n                      is too low for the use as a single marker, the addition of\n                      <jats:italic>GAS5<\/jats:italic>\n                      as a third marker improves the performance of the established marker panel. The benefit of\n                      <jats:italic>GAS5<\/jats:italic>\n                      for the detection of malignant mesothelioma at early stages needs to be validated in a prospective study.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40364-020-00194-4","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T10:04:03Z","timestamp":1589364243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies"],"prefix":"10.1186","volume":"8","author":[{"name":"the MoMar study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-8387","authenticated-orcid":false,"given":"Daniel G.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaantje","family":"Casjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Brik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Raiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Taeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gleichenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten T.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Johnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"issue":"12","key":"194_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/oemed-2017-104298","volume":"74","author":"CO Odgerel","year":"2017","unstructured":"Odgerel CO, Takahashi K, Sorahan T, Driscoll T, Fitzmaurice C, Yoko OM, et al. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med. 2017;74(12):851\u20138.","journal-title":"Occup Environ Med"},{"issue":"3","key":"194_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","volume":"92","author":"JT Hodgson","year":"2005","unstructured":"Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005;92(3):587\u201393.","journal-title":"Br J Cancer"},{"issue":"1","key":"194_CR3","doi-asserted-by":"publisher","first-page":"14321","DOI":"10.1038\/s41598-018-32315-3","volume":"8","author":"G Johnen","year":"2018","unstructured":"Johnen G, Burek K, Raiko I, Wichert K, Pesch B, Weber DG, et al. Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers. Sci Rep. 2018;8(1):14321.","journal-title":"Sci Rep"},{"issue":"5","key":"194_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.bbapap.2013.12.007","volume":"1844","author":"B Pesch","year":"2014","unstructured":"Pesch B, Bruning T, Johnen G, Casjens S, Bonberg N, Taeger D, et al. Biomarker research with prospective study designs for the early detection of cancer. Biochim Biophys Acta. 2014;1844(5):874\u201383.","journal-title":"Biochim Biophys Acta"},{"key":"194_CR5","first-page":"32","volume":"3","author":"EM Reis","year":"2012","unstructured":"Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in Cancer diagnostics. Front Genet. 2012;3:32.","journal-title":"Front Genet"},{"key":"194_CR6","doi-asserted-by":"crossref","unstructured":"Pardini B, Sabo AA, Birolo G, Calin GA. Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies. Cancers (Basel). 2019;11(8):E1170.","DOI":"10.3390\/cancers11081170"},{"issue":"3","key":"194_CR7","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1002\/jcb.27586","volume":"120","author":"M Matboli","year":"2019","unstructured":"Matboli M, Shafei AE, Ali MA, Gaber AI, Galal A, Tarek O, et al. Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma. J Cell Biochem. 2019;120(3):3203\u201311.","journal-title":"J Cell Biochem"},{"issue":"9","key":"194_CR8","doi-asserted-by":"publisher","first-page":"e7016","DOI":"10.1371\/journal.pone.0007016","volume":"4","author":"S Crispi","year":"2009","unstructured":"Crispi S, Calogero RA, Santini M, Mellone P, Vincenzi B, Citro G, et al. Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. PLoS One. 2009;4(9):e7016.","journal-title":"PLoS One"},{"issue":"1","key":"194_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2012.06.004","volume":"48","author":"X Zhang","year":"2012","unstructured":"Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012;48(1):1\u20138.","journal-title":"Neurobiol Dis"},{"issue":"9","key":"194_CR10","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"194_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s004200100240","volume":"74","author":"V Neumann","year":"2001","unstructured":"Neumann V, Gunthe S, Mulle KM, Fischer M. Malignant mesothelioma--German mesothelioma register 1987-1999. Int Arch Occup Environ Health. 2001;74(6):383\u201395.","journal-title":"Int Arch Occup Environ Health"},{"key":"194_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cca.2013.06.009","volume":"424","author":"NV Tolan","year":"2013","unstructured":"Tolan NV, Vidal-Folch N, Algeciras-Schimnich A, Singh RJ, Grebe SK. Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples. Clinica chimica acta; international journal of clinical chemistry. 2013;424:216\u201321.","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"1","key":"194_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/clinchem\/38.1.132","volume":"38","author":"VF Fairbanks","year":"1992","unstructured":"Fairbanks VF, Ziesmer SC, O'Brien PC. Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem. 1992;38(1):132\u201340.","journal-title":"Clin Chem"},{"issue":"1","key":"194_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/1756-0500-6-518","volume":"6","author":"DG Weber","year":"2013","unstructured":"Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, Jockel KH, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes. 2013;6(1):518.","journal-title":"BMC Res Notes."},{"key":"194_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.mrfmmm.2014.11.002","volume":"771","author":"O Melaiu","year":"2015","unstructured":"Melaiu O, Melissari E, Mutti L, Bracci E, De Santi C, Iofrida C, et al. Expression status of candidate genes in mesothelioma tissues and cell lines. Mutat Res. 2015;771:6\u201312.","journal-title":"Mutat Res"},{"issue":"1","key":"194_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11103-012-9885-2","volume":"80","author":"F Xie","year":"2012","unstructured":"Xie F, Xiao P, Chen D, Xu L, Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol. 2012;80(1):75\u201384.","journal-title":"Plant Mol Biol"},{"issue":"7","key":"194_CR17","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.","journal-title":"Genome Biol"},{"issue":"4","key":"194_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods."},{"issue":"1","key":"194_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-4598-5-24","volume":"5","author":"MD Mattie","year":"2006","unstructured":"Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 2006;5(1):24.","journal-title":"Mol Cancer"},{"issue":"6","key":"194_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/CBM-2007-3602","volume":"3","author":"DG Weber","year":"2007","unstructured":"Weber DG, Taeger D, Pesch B, Kraus T, Bruning T, Johnen G. Soluble mesothelin-related peptides (SMRP) - high stability of a potential tumor marker for mesothelioma. Cancer Biomark. 2007;3(6):287\u201392.","journal-title":"Cancer Biomark"},{"issue":"10","key":"194_CR21","doi-asserted-by":"publisher","first-page":"e25915","DOI":"10.1371\/journal.pone.0025915","volume":"6","author":"EA Gibb","year":"2011","unstructured":"Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY, et al. Human cancer long non-coding RNA transcriptomes. PLoS One. 2011;6(10):e25915.","journal-title":"PLoS One"},{"issue":"3","key":"194_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","volume":"47","author":"MK Iyer","year":"2015","unstructured":"Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47(3):199\u2013208.","journal-title":"Nat Genet"},{"issue":"8","key":"194_CR23","doi-asserted-by":"publisher","first-page":"e70940","DOI":"10.1371\/journal.pone.0070940","volume":"8","author":"CM Wright","year":"2013","unstructured":"Wright CM, Kirschner MB, Cheng YY, O'Byrne KJ, Gray SG, Schelch K, et al. Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM). PLoS One. 2013;8(8):e70940.","journal-title":"PLoS One"},{"key":"194_CR24","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.2147\/CMAR.S189052","volume":"11","author":"J Ji","year":"2019","unstructured":"Ji J, Dai X, Yeung SJ, He X. The role of long non-coding RNA GAS5 in cancers. Cancer Manag Res. 2019;11:2729\u201337.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"194_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1476-4598-13-119","volume":"13","author":"A Renganathan","year":"2014","unstructured":"Renganathan A, Kresoja-Rakic J, Echeverry N, Ziltener G, Vrugt B, Opitz I, et al. GAS5 long non-coding RNA in malignant pleural mesothelioma. Mol Cancer. 2014;13(1):119.","journal-title":"Mol Cancer"},{"issue":"8","key":"194_CR26","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.4161\/rna.21089","volume":"9","author":"M Eissmann","year":"2012","unstructured":"Eissmann M, Gutschner T, Hammerle M, Gunther S, Caudron-Herger M, Gross M, et al. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol. 2012;9(8):1076\u201387.","journal-title":"RNA Biol"},{"issue":"8","key":"194_CR27","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3727\/096504018X15166193231711","volume":"26","author":"W Li","year":"2018","unstructured":"Li W, Zhao W, Lu Z, Zhang W, Yang X. Long noncoding RNA GAS5 promotes proliferation, migration, and invasion by regulation of miR-301a in esophageal Cancer. Oncol Res. 2018;26(8):1285\u201394.","journal-title":"Oncol Res"},{"issue":"8","key":"194_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182305","volume":"12","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Su X, Kong Z, Fu F, Zhang P, Wang D, et al. An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation. PLoS One. 2017;12(8):e0182305.","journal-title":"PLoS One"},{"issue":"7\u20138","key":"194_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1947601913499020","volume":"4","author":"T Kogure","year":"2013","unstructured":"Kogure T, Yan IK, Lin WL, Patel T. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular Cancer. Genes & cancer. 2013;4(7\u20138):261\u201372.","journal-title":"Genes & cancer"},{"key":"194_CR30","doi-asserted-by":"crossref","unstructured":"Kresoja-Rakic J, Szpechcinski A, Kirschner MB, Ronner M, Minatel B, Martinez VD, et al. miR-625-3p and lncRNA GAS5 in liquid biopsies for predicting the outcome of malignant pleural mesothelioma patients treated with neo-adjuvant chemotherapy and surgery. Noncoding RNA. 2019;5(2).","DOI":"10.3390\/ncrna5020041"},{"issue":"37","key":"194_CR31","doi-asserted-by":"publisher","first-page":"e4608","DOI":"10.1097\/MD.0000000000004608","volume":"95","author":"W Liang","year":"2016","unstructured":"Liang W, Lv T, Shi X, Liu H, Zhu Q, Zeng J, et al. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer. Medicine (Baltimore). 2016;95(37):e4608.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"194_CR32","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/bab.1764","volume":"66","author":"LM Kamel","year":"2019","unstructured":"Kamel LM, Atef DM, Mackawy AMH, Shalaby SM, Abdelraheim N. Circulating long non-coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non-small cell lung cancer. Biotechnol Appl Biochem. 2019;66(4):634\u201342.","journal-title":"Biotechnol Appl Biochem"},{"issue":"11","key":"194_CR33","doi-asserted-by":"publisher","first-page":"20721","DOI":"10.1002\/jcp.28678","volume":"234","author":"C Li","year":"2019","unstructured":"Li C, Lv Y, Shao C, Chen C, Zhang T, Wei Y, et al. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis. J Cell Physiol. 2019;234(11):20721\u20137.","journal-title":"J Cell Physiol"},{"issue":"3","key":"194_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1158\/1940-6207.CAPR-10-0193","volume":"4","author":"CS Zhu","year":"2011","unstructured":"Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, et al. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res. 2011;4(3):375\u201383.","journal-title":"Cancer Prev Res"},{"issue":"3","key":"194_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1158\/1940-6207.CAPR-11-0053","volume":"4","author":"PL Mai","year":"2011","unstructured":"Mai PL, Wentzensen N, Greene MH. Challenges related to developing serum-based biomarkers for early ovarian cancer detection. Cancer Prev Res. 2011;4(3):303\u20136.","journal-title":"Cancer Prev Res"},{"issue":"1","key":"194_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12885-017-3375-5","volume":"17","author":"G Johnen","year":"2017","unstructured":"Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber DG, et al. Calretinin as a blood-based biomarker for mesothelioma. BMC Cancer. 2017;17(1):386.","journal-title":"BMC Cancer"},{"issue":"9","key":"194_CR37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.7150\/ijms.23939","volume":"15","author":"G Aguilar-Madrid","year":"2018","unstructured":"Aguilar-Madrid G, Pesch B, Calderon-Aranda ES, Burek K, Jimenez-Ramirez C, Juarez-Perez CA, et al. Biomarkers for predicting malignant pleural mesothelioma in a Mexican population. Int J Med Sci. 2018;15(9):883\u201391.","journal-title":"Int J Med Sci"},{"issue":"5","key":"194_CR38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00408-019-00244-1","volume":"197","author":"C Jimenez-Ramirez","year":"2019","unstructured":"Jimenez-Ramirez C, Casjens S, Juarez-Perez CA, Raiko I, Del Razo LM, Taeger D, et al. Mesothelin, Calretinin, and megakaryocyte potentiating factor as biomarkers of malignant pleural mesothelioma. Lung. 2019;197(5):641\u20139.","journal-title":"Lung."},{"issue":"2","key":"194_CR39","doi-asserted-by":"publisher","first-page":"e004145","DOI":"10.1136\/bmjopen-2013-004145","volume":"4","author":"A Cui","year":"2014","unstructured":"Cui A, Jin XG, Zhai K, Tong ZH, Shi HZ. Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis. BMJ Open. 2014;4(2):e004145.","journal-title":"BMJ Open"},{"issue":"9","key":"194_CR40","doi-asserted-by":"publisher","first-page":"e24145","DOI":"10.1371\/journal.pone.0024145","volume":"6","author":"MB Kirschner","year":"2011","unstructured":"Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One. 2011;6(9):e24145.","journal-title":"PLoS One"},{"issue":"4","key":"194_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1182\/blood-2013-10-530683","volume":"123","author":"JR Alvarez-Dominguez","year":"2014","unstructured":"Alvarez-Dominguez JR, Hu W, Yuan B, Shi J, Park SS, Gromatzky AA, et al. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2014;123(4):570\u201381.","journal-title":"Blood."},{"issue":"3","key":"194_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/10408363.2011.600228","volume":"48","author":"G Lippi","year":"2011","unstructured":"Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci. 2011;48(3):143\u201353.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"194_CR43","doi-asserted-by":"publisher","first-page":"9280170","DOI":"10.1155\/2017\/9280170","volume":"2017","author":"DG Weber","year":"2017","unstructured":"Weber DG, Gawrych K, Casjens S, Brik A, Lehnert M, Taeger D, et al. Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma. Dis Markers. 2017;2017:9280170.","journal-title":"Dis Markers"},{"key":"194_CR44","doi-asserted-by":"crossref","unstructured":"Early detection: a long road ahead. Nat Rev Cancer. 2018;18(7):401.","DOI":"10.1038\/s41568-018-0021-8"},{"issue":"1","key":"194_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13104-019-4113-7","volume":"12","author":"DG Weber","year":"2019","unstructured":"Weber DG, Brik A, Casjens S, Burek K, Lehnert M, Pesch B, et al. Are circulating microRNAs suitable for the early detection of malignant mesothelioma? Results from a nested case-control study. BMC Res Notes. 2019;12(1):77.","journal-title":"BMC Res Notes"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-020-00194-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-020-00194-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-020-00194-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T19:06:07Z","timestamp":1620846367000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-020-00194-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1186\/s40364-020-00194-4","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"29 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was designed according to the rules guarding patient privacy and with the approval from the ethics committee of the Ruhr University Bochum (Reference Number 3217\u201308). All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The IPA has supplied DLD Diagnostika GmbH with the antibodies to produce the Calretinin ELISA kits. In turn, the IPA has received Calretinin ELISA kits at a reduced price and may benefit from future sales of the kits. Otherwise, the individual authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}